Systems pharmacology modeling in neuroscience: Prediction and outcome of PF-04995274, a 5-HT4 partial agonist, in a clinical scopolamine impairment trial

Timothy Nicholas, Sridhar Duvvuri, Claire Leurent, David Raunig, Tracey Rapp, Phil Iredale, Carolyn Rowinski, Robert Carr, Patrick Roberts, Athan Spiros, Hugo Geerts
  • Advances in Alzheimer s Disease, January 2013, Scientific Research Publishing, Inc,
  • DOI: 10.4236/aad.2013.23012

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.4236/aad.2013.23012

The following have contributed to this page: Hugo Geerts